e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
Katherine J. Baines, Thomas K. Wright, Peter G. Gibson, Heather Powell, Philip M. Hansbro, Jodie L. Simpson
Source:
ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Katherine J. Baines, Thomas K. Wright, Peter G. Gibson, Heather Powell, Philip M. Hansbro, Jodie L. Simpson. Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD. ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Relationship between blood eosinophil count and bronchial epithelial gene expression in COPD versus Asthma
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018
A sputum gene expression signature predicts oral corticosteroid response in asthma
Source: Eur Respir J, 49 (6) 1700180; 10.1183/13993003.00180-2017
Year: 2017
Variation in the TLR4 gene and airway inflammation among patients with COPD
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Association of sputum chitinase like protein levels with pathophysiology and neutrophilic airway inflammation in asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005
Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Chronic sputum production in COPD is a marker for airway inflammation and colonisation
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018
Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Association between bacterial load and inflammatory gene expression in COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
The lung microbiota changes associated with inhaled corticosteroid and azithromycin in murine model of COPD
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Meta-analysis of airway epithelium gene expression in asthma
Source: Eur Respir J, 51 (5) 1701962; 10.1183/13993003.01962-2017
Year: 2018
Same role and same treatment for airway eosinophilia in asthma and COPD?
Source: Eur Respir J 2007; 29: 831-833
Year: 2007
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept